These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 17499997
1. The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Liu J, Shimizu K, Konishi F, Kumamoto S, Kondo R. Bioorg Med Chem; 2007 Jul 15; 15(14):4966-72. PubMed ID: 17499997 [Abstract] [Full Text] [Related]
2. Anti-androgen effects of extracts and compounds from Ganoderma lucidum. Liu J, Tamura S, Kurashiki K, Shimizu K, Noda K, Konishi F, Kumamoto S, Kondo R. Chem Biodivers; 2009 Feb 15; 6(2):231-43. PubMed ID: 19235153 [Abstract] [Full Text] [Related]
3. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Liu J, Shiono J, Shimizu K, Kukita A, Kukita T, Kondo R. Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2154-7. PubMed ID: 19289282 [Abstract] [Full Text] [Related]
4. Anti-androgenic activities of Ganoderma lucidum. Fujita R, Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Ueda C, Tajiri H, Kaneko S, Suimi Y, Kondo R. J Ethnopharmacol; 2005 Oct 31; 102(1):107-12. PubMed ID: 16029938 [Abstract] [Full Text] [Related]
5. Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum. Liu J, Kurashiki K, Shimizu K, Kondo R. Bioorg Med Chem; 2006 Dec 15; 14(24):8654-60. PubMed ID: 16962782 [Abstract] [Full Text] [Related]
6. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Zaidman BZ, Wasser SP, Nevo E, Mahajna J. Int J Oncol; 2007 Oct 15; 31(4):959-67. PubMed ID: 17786330 [Abstract] [Full Text] [Related]
7. Anti-androgenic activity of fatty acids. Liu J, Shimizu K, Kondo R. Chem Biodivers; 2009 Apr 15; 6(4):503-12. PubMed ID: 19353546 [Abstract] [Full Text] [Related]
8. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H, Eide T, Krobert KA, Levy FO, Dizeyi N, Bjartell AS, Abrahamsson PA, Taskén KA. Prostate; 2008 Jul 01; 68(10):1133-42. PubMed ID: 18454446 [Abstract] [Full Text] [Related]
9. Ganoderol B: a potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Fatmawati S, Shimizu K, Kondo R. Phytomedicine; 2011 Sep 15; 18(12):1053-5. PubMed ID: 21596546 [Abstract] [Full Text] [Related]
10. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q, Titus MA, Fung KM, Lin HK. J Cell Biochem; 2008 Aug 01; 104(5):1612-24. PubMed ID: 18320593 [Abstract] [Full Text] [Related]
11. Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells. Lee HH, Ho CT, Lin JK. Carcinogenesis; 2004 Jul 01; 25(7):1109-18. PubMed ID: 14963012 [Abstract] [Full Text] [Related]
12. Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer. Ho LL, Kench JG, Handelsman DJ, Scheffer GL, Stricker PD, Grygiel JG, Sutherland RL, Henshall SM, Allen JD, Horvath LG. Prostate; 2008 Sep 15; 68(13):1421-9. PubMed ID: 18615486 [Abstract] [Full Text] [Related]
13. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer. Jackson KM, Frazier MC, Harris WB. Anticancer Res; 2007 Sep 15; 27(3B):1483-8. PubMed ID: 17595765 [Abstract] [Full Text] [Related]
14. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts. Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ. Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029 [Abstract] [Full Text] [Related]
15. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M, Asim M, Eskelinen H, Linke T, Baniahmad A. J Mol Endocrinol; 2009 May 01; 42(5):429-35. PubMed ID: 19223455 [Abstract] [Full Text] [Related]
16. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines. Paliouras M, Diamandis EP. Biol Chem; 2008 Jun 01; 389(6):773-80. PubMed ID: 18627304 [Abstract] [Full Text] [Related]
17. FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Takayama K, Horie-Inoue K, Ikeda K, Urano T, Murakami K, Hayashizaki Y, Ouchi Y, Inoue S. Biochem Biophys Res Commun; 2008 Sep 19; 374(2):388-93. PubMed ID: 18640093 [Abstract] [Full Text] [Related]
18. Establishment of a novel immortalized human prostatic epithelial cell line stably expressing androgen receptor and its application for the functional screening of androgen receptor modulators. Yu S, Wang MW, Yao X, Chan FL. Biochem Biophys Res Commun; 2009 May 15; 382(4):756-61. PubMed ID: 19324023 [Abstract] [Full Text] [Related]
19. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum. Fatmawati S, Shimizu K, Kondo R. Fitoterapia; 2010 Dec 15; 81(8):1033-6. PubMed ID: 20603199 [Abstract] [Full Text] [Related]
20. Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 Cells. Lee I, Seo J, Kim J, Kim H, Youn U, Lee J, Jung H, Na M, Hattori M, Min B, Bae K. J Nat Prod; 2010 Feb 26; 73(2):172-6. PubMed ID: 20039640 [Abstract] [Full Text] [Related] Page: [Next] [New Search]